Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eeaWCfbwoceXllyluSsy

January 2, 2013
Sign upForwardArchiveAdvertiseRead more at SmartBrief.com
News for nuclear medicine and molecular imaging professionals
 
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at snmmi@smartbrief.com.

  Top Story 
  • Method improves detection of breast tissue microcalcifications
    A study published in Proceedings of the National Academy of Sciences showed a method called diffuse reflectance spectroscopy has a 97% success rate in detecting breast tissue with microcalcifications, which may indicate the tissue is cancerous. The method, which generates a "spectrographic signature" by collecting and analyzing light following interaction with the tissue, performs comparably with Raman spectroscopy and gives faster, less expensive results, researchers said. The team plans to test the method in real time while biopsies are being conducted in patients. Medical News Today (12/31) LinkedInFacebookTwitterEmail this Story
  Clinical News & Research 
  Industry Report 
  • 2012's top stories in biotechnology
    Genetic Engineering & Biotechnology News lists nine of the most important developments in the biotech industry for 2012. Among the stories for the year was the FDA's issuance in February of a draft guidance for the development and approval of biosimilar drugs. The threat of cuts as part of the "fiscal cliff" loomed over the budgets of the NIH, FDA, CDC and National Science Foundation. The year ended without a blockbuster merger or acquisition but with more new drug approvals from the FDA than 2011. Genetic Engineering & Biotechnology News (12/31) LinkedInFacebookTwitterEmail this Story
  News from the Field 
  • Foundation offers $9M for studies on gut disease biomarkers
    The Mayo Clinic and six other groups received $9 million from the Bill and Melinda Gates Foundation to finance efforts to identify biomarkers tied to gut function and disease. The Mayo Clinic will use its share of the funds to create a biomarker-based assay using mass spectrometry that detects an intestinal condition called environmental enteropathy, which afflicts 146 million children in developing countries. GenomeWeb Daily News (free registration) (12/27) LinkedInFacebookTwitterEmail this Story
  Health Policy 
  • Proposed device ID rule may result in changes to packaging lines
    The FDA's proposal to set up a unique device identifier system for medical technologies will compel firms to modify their packaging lines, which could be costly, according to this article. The FDA Safety and Innovation Act mandates that a final rule on the proposal be issued in the middle of May, not the middle of June as previously thought, but the agency "doesn't seem to be confident of meeting either possible deadline," said Jeffrey Secunda of the Advanced Medical Technology Association. Packaging World online (12/31) LinkedInFacebookTwitterEmail this Story
  Advancing Health Care 
  From SNMMI 
  • New self-assessment modules (SAMs) available!
    Take advantage of new Journal SAMs and earn credit! Popular SAMs include "Bringing Physiology into PET of the Liver," "Imaging of Multiple Myeloma and Related Plasma Cell Dyscrasias," "Modern Nuclear Imaging for Paragangliomas: Beyond SPECT" and "Effectiveness and Safety of FDG-PET in the Evaluation of Dementia." Get started today. LinkedInFacebookTwitterEmail this Story
SNMMI  |  News  |  Meetings  |  Education  |  Publications  |  Membership

SNMMI on Facebook  |  SNMMI on LinkedIn  |  SNMMI on Twitter  |  SNMMI on YouTube

  SmartQuote 
Birds sing after a storm; why shouldn't people feel as free to delight in whatever remains to them."
--Rose Kennedy,
American philanthropist


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
   
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Advertise
Account Director:   Meryl Harold   (202) 407-7828
 
Read more at SmartBrief.com
 
 
 Recent SNMMI SmartBrief Issues:   Lead Editor:   Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.®  Legal Information